EP1214404A4 - LINES OF EMBRYONIC OR STRAIN CELLS PRODUCED BY NUCLEAR TRANSPLANTATION OF CROSS SPECIES AND TECHNIQUE FOR ENHANCING EMBRYONIC DEVELOPMENT BY GENETIC MODIFICATION OF DONOR CELLS OR TISSUE CULTURE. - Google Patents
LINES OF EMBRYONIC OR STRAIN CELLS PRODUCED BY NUCLEAR TRANSPLANTATION OF CROSS SPECIES AND TECHNIQUE FOR ENHANCING EMBRYONIC DEVELOPMENT BY GENETIC MODIFICATION OF DONOR CELLS OR TISSUE CULTURE.Info
- Publication number
- EP1214404A4 EP1214404A4 EP00966717A EP00966717A EP1214404A4 EP 1214404 A4 EP1214404 A4 EP 1214404A4 EP 00966717 A EP00966717 A EP 00966717A EP 00966717 A EP00966717 A EP 00966717A EP 1214404 A4 EP1214404 A4 EP 1214404A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- embryonic
- lines
- technique
- tissue culture
- genetic modification
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 230000013020 embryo development Effects 0.000 title 1
- 230000002708 enhancing effect Effects 0.000 title 1
- 238000012239 gene modification Methods 0.000 title 1
- 230000005017 genetic modification Effects 0.000 title 1
- 235000013617 genetically modified food Nutrition 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000010449 nuclear transplantation Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2517/00—Cells related to new breeds of animals
- C12N2517/04—Cells produced using nuclear transfer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Psychology (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Developmental Biology & Embryology (AREA)
- Communicable Diseases (AREA)
- Physics & Mathematics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US39536899A | 1999-09-14 | 1999-09-14 | |
| PCT/US2000/025090 WO2001019977A1 (en) | 1999-09-14 | 2000-09-14 | Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| US395368 | 2002-07-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1214404A1 EP1214404A1 (en) | 2002-06-19 |
| EP1214404A4 true EP1214404A4 (en) | 2003-09-03 |
Family
ID=23562752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP00966717A Withdrawn EP1214404A4 (en) | 1999-09-14 | 2000-09-14 | LINES OF EMBRYONIC OR STRAIN CELLS PRODUCED BY NUCLEAR TRANSPLANTATION OF CROSS SPECIES AND TECHNIQUE FOR ENHANCING EMBRYONIC DEVELOPMENT BY GENETIC MODIFICATION OF DONOR CELLS OR TISSUE CULTURE. |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1214404A4 (en) |
| JP (1) | JP2003525031A (en) |
| CN (1) | CN1379814A (en) |
| AU (1) | AU7701900A (en) |
| BR (1) | BR0013999A (en) |
| CA (1) | CA2384413A1 (en) |
| IL (2) | IL148547A0 (en) |
| MX (1) | MXPA02002744A (en) |
| NZ (1) | NZ517609A (en) |
| WO (1) | WO2001019977A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7696404B2 (en) | 1996-08-19 | 2010-04-13 | Advanced Cell Technology, Inc. | Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| IL148418A0 (en) * | 1999-09-07 | 2002-09-12 | Advanced Cell Tech Inc | Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
| JP2003512052A (en) * | 1999-10-15 | 2003-04-02 | アドバンスド セル テクノロジー、インコーポレイテッド | Methods for producing differentiated progenitor cells and lineage-deleted embryonic stem cells |
| JP2004500066A (en) * | 1999-12-20 | 2004-01-08 | ユニバシティ オブ マサチューセッツ、ア パブリック インスチチユーション オブ ハイアー エデュケイション オブ ザ コモンウエルス オブ マサチューセッツ、アズ リプリゼンテッド バイ イッツ ア | Embryo or stem-like cells generated by xenogeneic nuclear transfer |
| US7221981B2 (en) | 2002-03-28 | 2007-05-22 | Northstar Neuroscience, Inc. | Electrode geometries for efficient neural stimulation |
| US10865383B2 (en) | 2011-07-12 | 2020-12-15 | Lineage Cell Therapeutics, Inc. | Methods and formulations for orthopedic cell therapy |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999005266A2 (en) * | 1997-07-26 | 1999-02-04 | Wisconsin Alumni Research Foundation | Trans-species nuclear transfer |
| WO2001046401A1 (en) * | 1999-12-20 | 2001-06-28 | University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus | Embryonic or stem-like cells produced by cross species nuclear transplantation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5843780A (en) * | 1995-01-20 | 1998-12-01 | Wisconsin Alumni Research Foundation | Primate embryonic stem cells |
| BR9711204A (en) * | 1996-08-19 | 1999-08-17 | Univ Massachusetts | Embryonic cell lines or similar are undifferentiated produced by nuclear transplantation of hybrid species |
| CN1299408A (en) * | 1998-03-02 | 2001-06-13 | 马萨诸塞大学 | Embryonic or stem cell-like cell lines produced by interspecific nuclear transfer |
-
2000
- 2000-09-14 NZ NZ517609A patent/NZ517609A/en unknown
- 2000-09-14 BR BR0013999-8A patent/BR0013999A/en not_active Application Discontinuation
- 2000-09-14 MX MXPA02002744A patent/MXPA02002744A/en not_active Application Discontinuation
- 2000-09-14 EP EP00966717A patent/EP1214404A4/en not_active Withdrawn
- 2000-09-14 WO PCT/US2000/025090 patent/WO2001019977A1/en not_active Ceased
- 2000-09-14 JP JP2001523749A patent/JP2003525031A/en active Pending
- 2000-09-14 AU AU77019/00A patent/AU7701900A/en not_active Abandoned
- 2000-09-14 IL IL14854700A patent/IL148547A0/en unknown
- 2000-09-14 CA CA002384413A patent/CA2384413A1/en not_active Abandoned
- 2000-09-14 CN CN00814278A patent/CN1379814A/en active Pending
-
2002
- 2002-03-06 IL IL148547A patent/IL148547A/en not_active IP Right Cessation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999005266A2 (en) * | 1997-07-26 | 1999-02-04 | Wisconsin Alumni Research Foundation | Trans-species nuclear transfer |
| WO2001046401A1 (en) * | 1999-12-20 | 2001-06-28 | University Of Massachusetts, A Public Institution Of Higher Education Of The Commonwealth Of Massachusetts, As Represented By Its Amherst Campus | Embryonic or stem-like cells produced by cross species nuclear transplantation |
Non-Patent Citations (4)
| Title |
|---|
| "CLAIM OF HUMAN-COW EMBRYO GREETED WITH SKEPTICISM", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE,, US, vol. 282, no. 1, 20 November 1998 (1998-11-20), pages 1390 - 1391, XP002930979, ISSN: 0036-8075 * |
| BLERKOM VAN J ET AL: "MITOCHONDRIAL TRANSFER BETWEEN OOCYTES: POTENTIAL APPLICATIONS OF MITOCHONDRIAL DONATION AND THE ISSUE OF HETEROPLASMY", HUMAN REPRODUCTION, IRL PRESS, OXFORD, GB, vol. 13, no. 10, 1998, pages 2857 - 2868, XP001002313, ISSN: 0268-1161 * |
| DOMINKO T ET AL: "BOVINE OOCYTE CYTOPLASM SUPPORTS DEVELOPMENT OF EMBRYOS PRODUCED BYNUCLEAR TRANSFER OF SOMATIC CELL NUCLEI FROM VARIOUS MAMMALIAN SPECIES", BIOLOGY OF REPRODUCTION, SOCIETY FOR THE STUDY OF REPRODUCTION, CHAMPAIGN, IL, US, vol. 60, no. 6, June 1999 (1999-06-01), pages 1496 - 1502, XP000920565, ISSN: 0006-3363 * |
| See also references of WO0119977A1 * |
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA02002744A (en) | 2003-07-21 |
| NZ517609A (en) | 2004-02-27 |
| CN1379814A (en) | 2002-11-13 |
| IL148547A (en) | 2009-09-01 |
| WO2001019977A9 (en) | 2002-09-26 |
| EP1214404A1 (en) | 2002-06-19 |
| JP2003525031A (en) | 2003-08-26 |
| CA2384413A1 (en) | 2001-03-22 |
| WO2001019977A1 (en) | 2001-03-22 |
| AU7701900A (en) | 2001-04-17 |
| BR0013999A (en) | 2002-05-21 |
| IL148547A0 (en) | 2002-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9711204A (en) | Embryonic cell lines or similar are undifferentiated produced by nuclear transplantation of hybrid species | |
| NO20022180D0 (en) | Hematopoietic differentiation of human embryonic stem cells | |
| CY1108712T1 (en) | METHOD FOR PRODUCING RESISTANT PLANTS IN DIFFERENT STRESS | |
| DE60037370D1 (en) | Sinusoidal cell culture module for the cultivation of hepatocytes | |
| DE69534227D1 (en) | SUBSTANCES AND METHODS FOR CONTROLLING THE HYPERACOUS EXTRACTION OF HUMAN TRANSPLANTS | |
| WO2000051424A3 (en) | Genetic modification of somatic cells and uses thereof | |
| ATE318307T1 (en) | CULTURE OF A CELL LINE FROM THE INNER CELL MASS OF UNGARDEN EMBRYOS. | |
| TR199902728T2 (en) | Phosphoribosyl transferaz quinolate ekspresyonun d'zenlenmesi. | |
| PL356025A1 (en) | Sugarbeet regeneration and transformation | |
| EP0270615A4 (en) | TRANSFORMATION OF CELL CULTURES AND EXPRESSION OF A FOREIGN GENE IN -i SPECIES (BRASSICA). | |
| CA2402299A1 (en) | Serum free cultivation of primate embryonic stem cells | |
| MXPA02004333A (en) | Use of haploid genomes for genetic diagnosis, modification and multiplication. | |
| NZ513888A (en) | Embryonic or stem-like cell lines produced by cross species nuclear transplantation | |
| EA199700004A1 (en) | Enhanced accummulation of trehalose in plants | |
| EP1135531A4 (en) | METHODS OF INTRODUCING HETEROLOGOUS CELLS IN FISH | |
| EP1463822A4 (en) | LATENT IMMUNODEFICIENCY VIRUS CELL LINES AND METHODS OF USE | |
| DK1131408T3 (en) | Cells, methods of culture and their use in autologous transplantation therapy | |
| IL150065A0 (en) | Embryonic or stem-like cells produced by cross species nuclear transplantation | |
| MXPA02002744A (en) | Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions. | |
| EP1513927A4 (en) | CREATION OF HISTOCOMPATIBLE TISSUES BY NUCLEAR TRANSPLANTATION | |
| FR2644894B1 (en) | ENZYMATIC DOSAGE KIT AND METHOD APPLICABLE TO WHOLE CELLS | |
| FR2622207B1 (en) | VECTORS FOR INTEGRATION AND EXPRESSION OF A HETEROLOGOUS GENE, CELLS INFECTED WITH SUCH VECTORS AND METHOD FOR THE PRODUCTION OF A PROTEIN OR GENETIC MODIFICATION OF ANIMALS | |
| DE59813854D1 (en) | TGC PROCESS FOR INDUCING A TARGETED, SOMATIC TRANSGENITY | |
| EP1188821A4 (en) | CARRIER FOR ANIMAL CELL CULTURE COMPRISING A BIOLOGICAL CUT OF AN ORGAN, CELL CULTURE ANIMAL AND TRANSPLANTATION METHOD BASED ON THE USE OF THIS CARRIER | |
| MXPA02002444A (en) | Method for generating immune compatible cells and tissues using nuclear transfer techniques. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20020408 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
| RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: ROBL, JAMES Inventor name: STICE, STEVEN, L. Inventor name: CIBELLI, JOSE |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20030717 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7C 12N 5/02 B Ipc: 7C 12N 5/00 B Ipc: 7C 12N 5/08 B Ipc: 7C 12N 15/00 A Ipc: 7A 01K 67/027 B Ipc: 7A 61K 48/00 B |
|
| 17Q | First examination report despatched |
Effective date: 20031107 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20040518 |